Nasal Cytology as a Complementary Cellular Window in Severe Asthma Phenotyping: Comments on the BRISA Study [Letter]

Journal of Asthma and Allergy · Published 2026-06-01 · DOI 10.2147/jaa.s635145

Free full text

Authors (1)

Matteo Gelardi

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Gelardi, M. (2026). Nasal Cytology as a Complementary Cellular Window in Severe Asthma Phenotyping: Comments on the BRISA Study [Letter]. Journal of Asthma and Allergy. https://doi.org/10.2147/jaa.s635145

Related articles

• Real-World Response to Dupilumab as Add-on Therapy in Adults and Adolescents with Type 2 Severe Asthma: A Spanish Cohort Study · Journal of Asthma and Allergy · 2026 · Same journal
• Characteristics of Adult Severe Uncontrolled Asthma Patients in Primary Care and Modifications in Prescribed Inhalation Treatments · Journal of Asthma and Allergy · 2026 · Same journal
• Thunderstorm-Associated Asthma in Shenzhen, China: A Retrospective Case-Control Study of Risk Factors, Clinical Characteristics, and Management Approaches · Journal of Asthma and Allergy · 2026 · Same journal
• Uncontrolled Asthma and Severe COVID-19: A Prospective Bidirectional Risk Analysis · Journal of Asthma and Allergy · 2026 · Same journal
• Prognostic Predictors of Bronchial Thermoplasty for Symptom Control in Severe Asthma · Journal of Asthma and Allergy · 2026 · Same journal
• Eosinophilic Gastroenteritis with Atopic Dermatitis: A Case Report and Literature Review · Journal of Asthma and Allergy · 2026 · Same journal
• Clonal Mast Cell Disorders and Mutation Profile in Adults Initially Presenting with Mast Cell Activation (Anaphylaxis) versus Non-Anaphylactic Presentations: A Joint Allergy–Hematology Cohort · Journal of Asthma and Allergy · 2026 · Same journal
• Associations Between Social Determinants of Health and Adherence to Biologic Therapies in Patients with Severe Asthma: Real-World Evidence from a Large US Claims Analysis · Journal of Asthma and Allergy · 2026 · Same journal
• Real-World Effectiveness and Safety of Single Inhaler Triple Therapy with Beclometasone/ Formoterol/ Glycopyrronium in Moderate to Severe Asthma: TriMaximize Study · Journal of Asthma and Allergy · 2026 · Same journal
• Intranasal Corticosteroids Versus Second-Generation Antihistamines for Allergic Rhinitis in Adolescents: A Prospective Cohort Study of Quality of Life and School Attendance · Journal of Asthma and Allergy · 2026 · Same journal